According to InterCure's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4569. At the end of 2023 the company had a P/S ratio of 0.6787.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.6787 | -48.93% |
2022 | 1.33 | -68.8% |
2021 | 4.26 | -39.68% |
2020 | 7.06 | -84.7% |
2019 | 46.1 | |
2015 | 12.1 |